Hartford Financial Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Hartford Financial Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-57	Closed	-$3K	–	368
2017 Q4	$3K	Hold	57	–	–	﹤0.01%	311
2017 Q3	$3K	Hold	57	–	–	﹤0.01%	351
2017 Q2	$3K	Hold	57	–	–	﹤0.01%	336
2017 Q1	$3K	Buy	+57	New	+$2.81K	﹤0.01%	319

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Hartford Financial Management's BIVV Position: Q1 2018 in Review

Hartford Financial Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 57 shares — an estimated $3K sold.

Hartford Financial Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Hartford Financial Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Hartford Financial Management sold 57 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3K.
Hartford Financial Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Hartford Financial Management's Bioverativ Inc. Common Stock position peaked at $3K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Hartford Financial Management's 13F filing for Q1 2018, filed 10 Apr 2018.